Fulminant Myocarditis in Adults and Children: Bi-Ventricular Assist Device for Recovery
In FM with intractable cardiogenic shock, the use of a BiVAD as a bridge to recovery is a life saving approach and should be considered before multi-end organ failure.
Atrial Fibrillation After Surgical Revascularization: Is There Any Difference Between On-Pump and Off-Pump?
There is no reduction of AF rate in myocardial revascularization without cardiopulmonary bypass.
Extracorporeal Cardiac Shock Wave Therapy Markedly Ameliorates Ischemia-Induced Myocardial Dysfunction in Pigs in Vivo
These results suggest that extracorporeal cardiac SW therapy is an effective and noninvasive therapeutic strategy for ischemic heart disease.
Intraoperative Use of Autologous Platelet-rich and Platelet-poor Plasma for Orthopedic Surgery Patients
Abstract: As use of autologous platelet-rich plasma (PRP) and platelet-poor plasma (PPP) increases for intraoperative care of a variety of patients, it […]
Sinus Floor Augmentation With Simultaneous Placement of Dental Implants in the Presence of Platelet-Rich Plasma or Recombinant Human Bone Morphogenetic Protein-7
The aim of the present study was to evaluate the possible benefit of platelet-rich plasma (PRP) in sinus grafting as compared with recombinant human bone morphogenetic protein-7 (rhBMP-7).
Identification of Pressure Passive Cerebral Perfusion and Its Mediators after Infant Cardiac Surgery
Absctract: Cerebrovascular pressure autoregulation (CPA) regulates cerebral blood flow (CBF) in relation to changes in mean arterial blood pressure (MAP). Identification of […]
Avoidance of Bleeding During Surgery in Patients Receiving Anticoagulant and/or Antiplatelet Therapy : Pharmacokinetic and Pharmacodynamic Considerations
Perioperative management of chronically anticoagulated patients and/or patients treated with antiplatelet therapy is a complex medical problem.
Trasylol Reduces Bleeding in CABG Patients on Anti-Platelet Therapy
In patients who require anti-platelet therapy, aprotinin (Trasylol; Bayer's) reduces blood loss and the need for blood transfusions during and after coronary artery bypass surgery, Bayer said on Tuesday.
Cytomedix, Inc. Expands Patent Litigation Representation by Engaging Leading Litigation Firm
Cytomedix, Inc. (OTC BB:CYME.OB - News) today announced an expansion of the company's patent litigation legal representation with the engagement of Fish & Richardson on a contingent fee basis.
Red Blood Cell Aggregation During Cardiopulmonary Bypass: A Pathogenic Cofactor in Endothelial Cell Activation?
RBC aggregation significantly drooped as consequence of blood dilution and blood–material interaction.
How Much Heparin Do We Really Need to Go on Pump? A Rethink of Current Practices
Patients receiving lower dose of heparin had lower postoperative blood loss.
Near-Infrared Spectroscopy for Monitoring Cerebral Ischemia During Selective Cerebral Perfusion
A sustained drop in rSO2 during aortic surgery is closely related to the occurrence of neurological events following surgery.